Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
复制标题
预测中国三阴性乳腺癌患者生存期的列线图的开发和验证
DOI:
10.1186/s12885-019-5703-4
复制
发表时间:
2019-06-06
期刊:
影响因子:
3.8
通讯作者:
Liu, Jieqiong
中科院分区:
文献类型:
--
作者:
Yang, Yaping;Wang, Ying;Liu, Jieqiong
BackgroundTriple negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Nomograms predicting outcomes of TNBC are needed for risk management.MethodsNomograms were based on an analysis of 296 non-metastatic TNBC patients treated at Sun Yat-sen Memorial Hospital from 2002 to 2014. The end points were disease-free survival (DFS) and overall survival (OS). Predictive accuracy and discriminative ability were evaluated by concordance index (C-index), area under the curve (AUC) and calibration curve, and compared with the American Joint Committee on Cancer (AJCC) staging system, PREDICT and CancerMath. Models were subjected to bootstrap internal validation and external validation using independent cohorts of 191 patients from the second Xiangya Hospital and Peking University Shenzhen Hospital between 2007 and 2012.ResultsOn multivariable analysis of training cohort, independent prognostic factors were stromal tumor-infiltrating lymphocytes (TILs), tumor size, node status, and Ki67 index, which were then selected into the nomograms. The calibration curves for probability of DFS and OS showed optimal agreement between nomogram prediction and actual observation. The C-index of nomograms was significantly higher than that of the seventh and eighth AJCC staging system for predicting DFS (training: 0.743 vs 0.666 (P=0.003) and 0.664 (P=0.024); validation: 0.784 vs 0.632 (P=0.02) and 0.607 (P=0.002)) and OS (training: 0.791 vs 0.683 (P=0.004) and 0.677 (P